Breakdown | |||||
TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
3.36B | 3.29B | 3.08B | 2.89B | 2.59B | 2.48B | Gross Profit |
1.60B | 1.60B | 1.44B | 1.39B | 1.28B | 1.23B | EBIT |
226.01M | 247.35M | 57.31M | 63.97M | 123.51M | 170.35M | EBITDA |
389.29M | 400.03M | 245.00M | 284.44M | 229.03M | 246.79M | Net Income Common Stockholders |
159.53M | 173.68M | -185.98M | -50.57M | -74.94M | 83.36M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
224.43M | 208.28M | 168.85M | 327.00M | 335.27M | 45.02M | Total Assets |
1.92B | 1.89B | 1.85B | 2.17B | 2.18B | 1.82B | Total Debt |
1.67B | 1.72B | 1.76B | 1.79B | 1.89B | 1.63B | Net Debt |
1.45B | 1.52B | 1.63B | 1.52B | 1.70B | 1.59B | Total Liabilities |
2.45B | 2.41B | 2.47B | 2.53B | 2.56B | 2.15B | Stockholders Equity |
-554.47M | -550.15M | -623.14M | -494.92M | -449.37M | -407.48M |
Cash Flow | Free Cash Flow | ||||
218.73M | 237.49M | 18.73M | 100.20M | 165.76M | 243.99M | Operating Cash Flow |
312.40M | 350.72M | 130.29M | 219.54M | 265.22M | 338.44M | Investing Cash Flow |
-86.94M | -54.61M | -103.72M | -4.00M | -354.32M | -66.86M | Financing Cash Flow |
-268.16M | -222.55M | -177.11M | -106.57M | 224.13M | -258.25M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $188.60B | 34.95 | 36.31% | ― | 11.02% | 4.96% | |
66 Neutral | $64.21B | 60.78 | 26.13% | ― | 13.48% | 0.66% | |
66 Neutral | $28.08B | 48.96 | 10.03% | ― | 12.11% | 14.35% | |
63 Neutral | $66.59B | 31.85 | 16.27% | ― | -1.19% | 48.33% | |
63 Neutral | $18.92B | 48.51 | 12.99% | ― | 6.05% | 63.78% | |
59 Neutral | $29.20B | 0.14 | -13.78% | 4.02% | 2.18% | -51.50% | |
54 Neutral | $1.10B | 7.02 | -27.42% | ― | 4.60% | 303.80% |
At Cimpress plc’s Annual General Meeting on November 20, 2024, shareholders voted on several key proposals, including reappointing Dessislava Temperley to the Board of Directors, approving executive compensation, and amending the 2020 Equity Incentive Plan. They also renewed the Board’s authority to issue shares and opt out of preemption rights. PricewaterhouseCoopers Ireland was reappointed as the statutory auditor, and the Board or Audit Committee was authorized to set its remuneration.